Shenzhen Bioeasy Biotechnology Co., Ltd. (300942.SZ)
CNY 8.76
(-0.23%)
CNY 8.76
(-0.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -115.17 Million CNY | -278.68% |
| 2022 | 98.1 Million CNY | -63.43% |
| 2021 | 268.27 Million CNY | 257.2% |
| 2020 | 75.1 Million CNY | -28.63% |
| 2019 | 105.23 Million CNY | 24.1% |
| 2018 | 84.79 Million CNY | 90.74% |
| 2017 | 44.45 Million CNY | 169.78% |
| 2016 | 16.47 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -5.12 Million CNY | 93.61% |
| 2024 Q2 | 4.1 Million CNY | 221.0% |
| 2023 Q1 | -33.53 Million CNY | 56.97% |
| 2023 Q3 | -11.29 Million CNY | 77.53% |
| 2023 Q2 | -50.25 Million CNY | -49.87% |
| 2023 FY | -175.3 Million CNY | -278.68% |
| 2023 Q4 | -80.21 Million CNY | -610.28% |
| 2022 Q2 | 45.29 Million CNY | -67.48% |
| 2022 Q4 | -77.92 Million CNY | -812.41% |
| 2022 Q1 | 139.28 Million CNY | 214.76% |
| 2022 Q3 | -8.54 Million CNY | -118.86% |
| 2022 FY | 98.1 Million CNY | -63.43% |
| 2021 Q1 | 95.51 Million CNY | 492.38% |
| 2021 Q2 | 87.28 Million CNY | -8.62% |
| 2021 Q3 | 41.23 Million CNY | -52.76% |
| 2021 Q4 | 44.24 Million CNY | 7.31% |
| 2021 FY | 268.27 Million CNY | 257.2% |
| 2020 Q3 | 13.42 Million CNY | 188.89% |
| 2020 Q1 | 40.91 Million CNY | -7.54% |
| 2020 FY | 75.1 Million CNY | -28.63% |
| 2020 Q4 | 16.12 Million CNY | 20.13% |
| 2020 Q2 | 4.64 Million CNY | -88.64% |
| 2019 Q4 | 44.25 Million CNY | 0.0% |
| 2019 FY | 105.23 Million CNY | 24.1% |
| 2019 Q1 | 14.95 Million CNY | 0.0% |
| 2018 FY | 84.79 Million CNY | 90.74% |
| 2017 FY | 44.45 Million CNY | 169.78% |
| 2016 FY | 16.47 Million CNY | 0.0% |